On January 7, 2014, NAMSA, one of the world's leading medical research organizations, acquired Medvance, a full-service clinical research and resourcing organization that specialized in medical devices, in-vitro diagnostics (IVDs), and combination product.

The combined resources and expertise of NAMSA and Medvance will enable the integrated company to deliver a broader range of services, increase operational efficiencies, and provide clients with an unparalleled level of support throughout the product development lifecycle. The acquisition further solidifies NAMSA's commitment to advancing medical research and facilitating the delivery of safe and effective medical devices to the market.